China Pharmacovigilance (PV) Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Pharmacovigilance (PV) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • ArisGlobal

    • IBM Corporation

    • Clinquest Group BV

    • PAREXEL International Corporation

    • Cognizant

    • iMEDGlobal

    • BioClinica

    • Foresight Group International AG

    • United BioSource Corporation

    • ICON plc

    • Accenture

    • Wipro Ltd

    • TAKE Solutions Ltd

    By Type:

    • Targeted Spontaneous Reporting

    • EHR Mining

    • Intensified ADR Reporting

    • Cohort Event Monitoring

    • Spontaneous Reporting

    By Application:

    • Hospitals

    • Industrial

    • Research Organizations

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Pharmacovigilance (PV) Market Overview 2018-2029

    • 1.1 China Pharmacovigilance (PV) Industry Development Overview

    • 1.2 China Pharmacovigilance (PV) Industry Development History

    • 1.3 China Pharmacovigilance (PV) Industry Market Size (2018-2029)

    • 1.4 China Pharmacovigilance (PV) Market Analysis by Type from Production Side

      • 1.4.1 China Pharmacovigilance (PV) Production Volume, Production Value and Growth Rate of Targeted Spontaneous Reporting (2018-2029)

      • 1.4.2 China Pharmacovigilance (PV) Production Volume, Production Value and Growth Rate of EHR Mining (2018-2029)

      • 1.4.3 China Pharmacovigilance (PV) Production Volume, Production Value and Growth Rate of Intensified ADR Reporting (2018-2029)

      • 1.4.4 China Pharmacovigilance (PV) Production Volume, Production Value and Growth Rate of Cohort Event Monitoring (2018-2029)

      • 1.4.5 China Pharmacovigilance (PV) Production Volume, Production Value and Growth Rate of Spontaneous Reporting (2018-2029)

    • 1.5 China Pharmacovigilance (PV) Market Analysis by Application from Consumption End

      • 1.5.1 China Pharmacovigilance (PV) Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.2 China Pharmacovigilance (PV) Sales Volume, Sales Value and Growth Rate of Industrial (2018-2029)

      • 1.5.3 China Pharmacovigilance (PV) Sales Volume, Sales Value and Growth Rate of Research Organizations (2018-2029)

    • 1.6 China Pharmacovigilance (PV) Market Analysis by Region

      • 1.6.1 North China Pharmacovigilance (PV) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Pharmacovigilance (PV) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Pharmacovigilance (PV) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Pharmacovigilance (PV) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Pharmacovigilance (PV) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Pharmacovigilance (PV) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Pharmacovigilance (PV) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Pharmacovigilance (PV) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Pharmacovigilance (PV) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Pharmacovigilance (PV) Market Status and Competition Analysis in 2023

      • 2.2.3 China Pharmacovigilance (PV) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Pharmacovigilance (PV) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Pharmacovigilance (PV) Industry Development

    Chapter 3 Pharmacovigilance (PV)Industry Chain Analysis

    • 3.1 Pharmacovigilance (PV) Industry Chain

    • 3.2 Pharmacovigilance (PV) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Pharmacovigilance (PV) Market

    • 3.3 Pharmacovigilance (PV) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Pharmacovigilance (PV) Market

    Chapter 4 China Pharmacovigilance (PV) Market, by Type

    • 4.1 China Pharmacovigilance (PV) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Pharmacovigilance (PV) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Pharmacovigilance (PV) Production Volume and Growth Rate, by Type

      • 4.5.1 China Pharmacovigilance (PV) Production Volume and Growth Rate of Targeted Spontaneous Reporting

      • 4.5.2 China Pharmacovigilance (PV) Production Volume and Growth Rate of EHR Mining

      • 4.5.3 China Pharmacovigilance (PV) Production Volume and Growth Rate of Intensified ADR Reporting

      • 4.5.4 China Pharmacovigilance (PV) Production Volume and Growth Rate of Cohort Event Monitoring

      • 4.5.5 China Pharmacovigilance (PV) Production Volume and Growth Rate of Spontaneous Reporting

    Chapter 5 China Pharmacovigilance (PV) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Pharmacovigilance (PV) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Pharmacovigilance (PV) Market Size and Growth Rate, by Application

      • 5.5.1 China Pharmacovigilance (PV) Market Size and Growth Rate of Hospitals

      • 5.5.2 China Pharmacovigilance (PV) Market Size and Growth Rate of Industrial

      • 5.5.3 China Pharmacovigilance (PV) Market Size and Growth Rate of Research Organizations

    Chapter 6 China Pharmacovigilance (PV) Market, by Region

    • 6.1 China Pharmacovigilance (PV) Production Volume and Production Value, by Region

    • 6.2 China Pharmacovigilance (PV) Sales Volume and Sales Value, by Region

    Chapter 7 North China Pharmacovigilance (PV) Market Analysis

    • 7.1 North China Pharmacovigilance (PV) Market, by Type

    • 7.2 North China Pharmacovigilance (PV) Market, by Application

    Chapter 8 Central China Pharmacovigilance (PV) Market Analysis

    • 8.1 Central China Pharmacovigilance (PV) Market, by Type

    • 8.2 Central China Pharmacovigilance (PV) Market, by Application

    Chapter 9 South China Pharmacovigilance (PV) Market Analysis

    • 9.1 South China Pharmacovigilance (PV) Market, by Type

    • 9.2 South China Pharmacovigilance (PV) Market, by Application

    Chapter 10 East China Pharmacovigilance (PV) Market Analysis

    • 10.1 East China Pharmacovigilance (PV) Market, by Type

    • 10.2 East China Pharmacovigilance (PV) Market, by Application

    Chapter 11 Northeast China Pharmacovigilance (PV) Market Analysis

    • 11.1 Northeast China Pharmacovigilance (PV) Market, by Type

    • 11.2 Northeast China Pharmacovigilance (PV) Market, by Application

    Chapter 12 Southwest China Pharmacovigilance (PV) Market Analysis

    • 12.1 Southwest China Pharmacovigilance (PV) Market, by Type

    • 12.2 Southwest China Pharmacovigilance (PV) Market, by Application

    Chapter 13 Northwest China Pharmacovigilance (PV) Market Analysis

    • 13.1 Northwest China Pharmacovigilance (PV) Market, by Type

    • 13.2 Northwest China Pharmacovigilance (PV) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 ArisGlobal

        • 14.1.1 ArisGlobal Company Profile

        • 14.1.2 ArisGlobal Pharmacovigilance (PV) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 IBM Corporation

        • 14.2.1 IBM Corporation Company Profile

        • 14.2.2 IBM Corporation Pharmacovigilance (PV) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Clinquest Group BV

        • 14.3.1 Clinquest Group BV Company Profile

        • 14.3.2 Clinquest Group BV Pharmacovigilance (PV) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 PAREXEL International Corporation

        • 14.4.1 PAREXEL International Corporation Company Profile

        • 14.4.2 PAREXEL International Corporation Pharmacovigilance (PV) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Cognizant

        • 14.5.1 Cognizant Company Profile

        • 14.5.2 Cognizant Pharmacovigilance (PV) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 iMEDGlobal

        • 14.6.1 iMEDGlobal Company Profile

        • 14.6.2 iMEDGlobal Pharmacovigilance (PV) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 BioClinica

        • 14.7.1 BioClinica Company Profile

        • 14.7.2 BioClinica Pharmacovigilance (PV) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Foresight Group International AG

        • 14.8.1 Foresight Group International AG Company Profile

        • 14.8.2 Foresight Group International AG Pharmacovigilance (PV) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 United BioSource Corporation

        • 14.9.1 United BioSource Corporation Company Profile

        • 14.9.2 United BioSource Corporation Pharmacovigilance (PV) Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 ICON plc

        • 14.10.1 ICON plc Company Profile

        • 14.10.2 ICON plc Pharmacovigilance (PV) Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Accenture

        • 14.11.1 Accenture Company Profile

        • 14.11.2 Accenture Pharmacovigilance (PV) Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Wipro Ltd

        • 14.12.1 Wipro Ltd Company Profile

        • 14.12.2 Wipro Ltd Pharmacovigilance (PV) Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 TAKE Solutions Ltd

        • 14.13.1 TAKE Solutions Ltd Company Profile

        • 14.13.2 TAKE Solutions Ltd Pharmacovigilance (PV) Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Pharmacovigilance (PV) Industry Research Conclusions

    • 15.2 Pharmacovigilance (PV) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Pharmacovigilance (PV) Industry Market Size (2018-2029)

    • Figure China Pharmacovigilance (PV) Production Volume, Production Value and Growth Rate of Targeted Spontaneous Reporting (2018-2029)

    • Figure China Pharmacovigilance (PV) Production Volume, Production Value and Growth Rate of EHR Mining (2018-2029)

    • Figure China Pharmacovigilance (PV) Production Volume, Production Value and Growth Rate of Intensified ADR Reporting (2018-2029)

    • Figure China Pharmacovigilance (PV) Production Volume, Production Value and Growth Rate of Cohort Event Monitoring (2018-2029)

    • Figure China Pharmacovigilance (PV) Production Volume, Production Value and Growth Rate of Spontaneous Reporting (2018-2029)

    • Figure China Pharmacovigilance (PV) Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Pharmacovigilance (PV) Sales Volume, Sales Value and Growth Rate of Industrial (2018-2029)

    • Figure China Pharmacovigilance (PV) Sales Volume, Sales Value and Growth Rate of Research Organizations (2018-2029)

    • Figure North China Pharmacovigilance (PV) Market Size and Growth Rate from 2018-2029

    • Figure Central China Pharmacovigilance (PV) Market Size and Growth Rate from 2018-2029

    • Figure South China Pharmacovigilance (PV) Market Size and Growth Rate from 2018-2029

    • Figure East China Pharmacovigilance (PV) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Pharmacovigilance (PV) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Pharmacovigilance (PV) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Pharmacovigilance (PV) Market Size and Growth Rate from 2018-2029

    • Figure Pharmacovigilance (PV) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Pharmacovigilance (PV) Market Share by Type in 2018

    • Figure China Pharmacovigilance (PV) Market Share by Type in 2023

    • Figure China Pharmacovigilance (PV) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Pharmacovigilance (PV) Production Volume and Growth Rate of Targeted Spontaneous Reporting (2018-2023)

    • Figure China Pharmacovigilance (PV) Production Volume and Growth Rate of EHR Mining (2018-2023)

    • Figure China Pharmacovigilance (PV) Production Volume and Growth Rate of Intensified ADR Reporting (2018-2023)

    • Figure China Pharmacovigilance (PV) Production Volume and Growth Rate of Cohort Event Monitoring (2018-2023)

    • Figure China Pharmacovigilance (PV) Production Volume and Growth Rate of Spontaneous Reporting (2018-2023)

    • Figure China Pharmacovigilance (PV) Market Share by Application in 2018

    • Figure China Pharmacovigilance (PV) Market Share by Application in 2023

    • Figure China Pharmacovigilance (PV) Total Market Size and Growth Rate from Consumption End

    • Figure China Pharmacovigilance (PV) Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Pharmacovigilance (PV) Market Size and Growth Rate of Industrial (2018-2023)

    • Figure China Pharmacovigilance (PV) Market Size and Growth Rate of Research Organizations (2018-2023)

    • Table China Pharmacovigilance (PV) Production Volume by Region (2018-2023)

    • Table China Pharmacovigilance (PV) Production Volume Share by Region (2018-2023)

    • Figure China Pharmacovigilance (PV) Production Volume Share by Region (2018-2023)

    • Table China Pharmacovigilance (PV) Production Value by Region (2018-2023)

    • Table China Pharmacovigilance (PV) Production Value Share by Region (2018-2023)

    • Figure China Pharmacovigilance (PV) Production Value Share by Region (2018-2023)

    • Table China Pharmacovigilance (PV) Sales Volume by Region (2018-2023)

    • Table China Pharmacovigilance (PV) Sales Volume Share by Region (2018-2023)

    • Figure China Pharmacovigilance (PV) Sales Volume Share by Region (2018-2023)

    • Table China Pharmacovigilance (PV) Sales Value by Region (2018-2023)

    • Table China Pharmacovigilance (PV) Sales Value Share by Region (2018-2023)

    • Figure China Pharmacovigilance (PV) Sales Value Share by Region (2018-2023)

    • Table North China Pharmacovigilance (PV) Production Volume by Type (2018-2023)

    • Table North China Pharmacovigilance (PV) Production Volume Share by Type (2018-2023)

    • Figure North China Pharmacovigilance (PV) Production Volume Share by Type (2018-2023)

    • Table North China Pharmacovigilance (PV) Sales Volume by Application (2018-2023)

    • Table North China Pharmacovigilance (PV) Sales Volume Share by Application (2018-2023)

    • Figure North China Pharmacovigilance (PV) Sales Volume Share by Application (2018-2023)

    • Table Central China Pharmacovigilance (PV) Production Volume by Type (2018-2023)

    • Table Central China Pharmacovigilance (PV) Production Volume Share by Type (2018-2023)

    • Figure Central China Pharmacovigilance (PV) Production Volume Share by Type (2018-2023)

    • Table Central China Pharmacovigilance (PV) Sales Volume by Application (2018-2023)

    • Table Central China Pharmacovigilance (PV) Sales Volume Share by Application (2018-2023)

    • Figure Central China Pharmacovigilance (PV) Sales Volume Share by Application (2018-2023)

    • Table South China Pharmacovigilance (PV) Production Volume by Type (2018-2023)

    • Table South China Pharmacovigilance (PV) Production Volume Share by Type (2018-2023)

    • Figure South China Pharmacovigilance (PV) Production Volume Share by Type (2018-2023)

    • Table South China Pharmacovigilance (PV) Sales Volume by Application (2018-2023)

    • Table South China Pharmacovigilance (PV) Sales Volume Share by Application (2018-2023)

    • Figure South China Pharmacovigilance (PV) Sales Volume Share by Application (2018-2023)

    • Table East China Pharmacovigilance (PV) Production Volume by Type (2018-2023)

    • Table East China Pharmacovigilance (PV) Production Volume Share by Type (2018-2023)

    • Figure East China Pharmacovigilance (PV) Production Volume Share by Type (2018-2023)

    • Table East China Pharmacovigilance (PV) Sales Volume by Application (2018-2023)

    • Table East China Pharmacovigilance (PV) Sales Volume Share by Application (2018-2023)

    • Figure East China Pharmacovigilance (PV) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Pharmacovigilance (PV) Production Volume by Type (2018-2023)

    • Table Northeast China Pharmacovigilance (PV) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Pharmacovigilance (PV) Production Volume Share by Type (2018-2023)

    • Table Northeast China Pharmacovigilance (PV) Sales Volume by Application (2018-2023)

    • Table Northeast China Pharmacovigilance (PV) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Pharmacovigilance (PV) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Pharmacovigilance (PV) Production Volume by Type (2018-2023)

    • Table Southwest China Pharmacovigilance (PV) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Pharmacovigilance (PV) Production Volume Share by Type (2018-2023)

    • Table Southwest China Pharmacovigilance (PV) Sales Volume by Application (2018-2023)

    • Table Southwest China Pharmacovigilance (PV) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Pharmacovigilance (PV) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Pharmacovigilance (PV) Production Volume by Type (2018-2023)

    • Table Northwest China Pharmacovigilance (PV) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Pharmacovigilance (PV) Production Volume Share by Type (2018-2023)

    • Table Northwest China Pharmacovigilance (PV) Sales Volume by Application (2018-2023)

    • Table Northwest China Pharmacovigilance (PV) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Pharmacovigilance (PV) Sales Volume Share by Application (2018-2023)

    • Table ArisGlobal Company Profile

    • Table ArisGlobal Pharmacovigilance (PV) Revenue, Price and Gross (2018-2023)

    • Table IBM Corporation Company Profile

    • Table IBM Corporation Pharmacovigilance (PV) Revenue, Price and Gross (2018-2023)

    • Table Clinquest Group BV Company Profile

    • Table Clinquest Group BV Pharmacovigilance (PV) Revenue, Price and Gross (2018-2023)

    • Table PAREXEL International Corporation Company Profile

    • Table PAREXEL International Corporation Pharmacovigilance (PV) Revenue, Price and Gross (2018-2023)

    • Table Cognizant Company Profile

    • Table Cognizant Pharmacovigilance (PV) Revenue, Price and Gross (2018-2023)

    • Table iMEDGlobal Company Profile

    • Table iMEDGlobal Pharmacovigilance (PV) Revenue, Price and Gross (2018-2023)

    • Table BioClinica Company Profile

    • Table BioClinica Pharmacovigilance (PV) Revenue, Price and Gross (2018-2023)

    • Table Foresight Group International AG Company Profile

    • Table Foresight Group International AG Pharmacovigilance (PV) Revenue, Price and Gross (2018-2023)

    • Table United BioSource Corporation Company Profile

    • Table United BioSource Corporation Pharmacovigilance (PV) Revenue, Price and Gross (2018-2023)

    • Table ICON plc Company Profile

    • Table ICON plc Pharmacovigilance (PV) Revenue, Price and Gross (2018-2023)

    • Table Accenture Company Profile

    • Table Accenture Pharmacovigilance (PV) Revenue, Price and Gross (2018-2023)

    • Table Wipro Ltd Company Profile

    • Table Wipro Ltd Pharmacovigilance (PV) Revenue, Price and Gross (2018-2023)

    • Table TAKE Solutions Ltd Company Profile

    • Table TAKE Solutions Ltd Pharmacovigilance (PV) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.